Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Hikma Labs Inc.

Home Clinical Trial Sponsors and OrganizationsHikma Labs Inc.

Hikma Labs Inc.

1900 Arlingate Ln, Columbus, Ohio, United States

Also known as:

roxane laboratories

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

99

0 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

81

81.8%

Phase 1

10

10.1%

Early Phase 1

6

6.1%

Phase 3

1

1.0%

Phase 4

1

1.0%

Trial Status Distribution

Completed

98

99.0%

Terminated

1

1.0%

Clinical Trials

Trials sponsored by this organization (99)

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

Aug 20141,430 participants

A Study of Oral Codeine Sulfate in Pediatric Patients With Post-procedural Pain

Apr 201231 participants

Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects

Apr 201150 participants

Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions

Sep 200959 participants

Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions

Sep 200964 participants

Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

Sep 200928 participants

Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions

Feb 200927 participants

Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fasted Conditions

Feb 200926 participants

Page 1 of 13

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials99
Approvals
News

Back to Organizations